These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9826982)

  • 1. Outcome measures in spasticity management.
    Pierson SH
    Muscle Nerve Suppl; 1997; 6():S36-60. PubMed ID: 9826982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measuring outcome in spasticity rehabilitation].
    Fheodoroff K; Wissel J; Entner T; Freimüller M
    Wien Klin Wochenschr; 2001; 113 Suppl 4():11-5. PubMed ID: 15506046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of botulinum toxin in the treatment of spasticity.
    Simpson DM
    Muscle Nerve Suppl; 1997; 6():S169-75. PubMed ID: 9826988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.
    Albany K
    Muscle Nerve Suppl; 1997; 6():S221-31. PubMed ID: 9826993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E; Roze E; Abada G; Lemesle C; Vidailhet M; Laurent-Vannier A; Chevignard MP
    Dev Neurorehabil; 2009 Jun; 12(3):128-38. PubMed ID: 19466620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a pulsed electromagnetic therapy on multiple sclerosis fatigue and quality of life: a double-blind, placebo controlled trial.
    Lappin MS; Lawrie FW; Richards TL; Kramer ED
    Altern Ther Health Med; 2003; 9(4):38-48. PubMed ID: 12868251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spinal cord injury spasticity evaluation tool: development and evaluation.
    Adams MM; Ginis KA; Hicks AL
    Arch Phys Med Rehabil; 2007 Sep; 88(9):1185-92. PubMed ID: 17826466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of measures of breathlessness.
    Cullen DL; Rodak B
    Respir Care; 2002 Sep; 47(9):986-93. PubMed ID: 12188932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a multimodal management of prematurity-related spasticity.
    Papavasiliou AS; Rapidi CA; Filiopoulos C; Rizou C; Skouteli HN
    Pediatr Neurol; 2006 Dec; 35(6):400-7. PubMed ID: 17138009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.
    Cousins E; Ward AB; Roffe C; Rimington LD; Pandyan AD
    Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH; Neo JJ; Chua KS
    Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional health outcomes as a measure of health care quality for Medicare beneficiaries.
    Bierman AS; Lawrence WF; Haffer SC; Clancy CM
    Health Serv Res; 2001 Dec; 36(6 Pt 2):90-109. PubMed ID: 16148963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity.
    Turkel CC; Bowen B; Liu J; Brin MF
    Arch Phys Med Rehabil; 2006 Jun; 87(6):786-92. PubMed ID: 16731213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromyographic response to manual passive stretch of the hemiplegic wrist: accuracy, reliability, and correlation with clinical spasticity assessment and function.
    Sorinola IO; White CM; Rushton DN; Newham DJ
    Neurorehabil Neural Repair; 2009; 23(3):287-94. PubMed ID: 19050174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical treatment (non surgical) of spasticity in cerebral palsy].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):1-6. PubMed ID: 11988886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adjusted outcome models for public mental health outpatient programs.
    Hendryx MS; Dyck DG; Srebnik D
    Health Serv Res; 1999 Apr; 34(1 Pt 1):171-95. PubMed ID: 10201857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.